Baculoviral chitinase (CHIA) and cysteine protease cathepsin (V-CATH) are interdependent for insect liquefaction (Hawtin et al., 1997) . Autographa californica multiple nucleopolyhedrovirus (AcMNPV) and other alphabaculovirus group I nucleopolyhedroviruses (NPVs) have a wellconserved chiA/v-cath gene locus (Slack et al., 2004) . The proper folding of proV-CATH, the progenitor of the viral cysteine protease, cathepsin (V-CATH), requires active CHIA (Hom & Volkman, 2000; Daimon et al., 2007) , without which proV-CATH forms insoluble aggregates. The AcMNPV proV-CATH is glycosylated at Asn , but not at the other predicted N-linkage motif at Asn 158 . In addition, tunicamycin inhibition of N-linked glycosylation results in aggregation of proV-CATH (Hom & Volkman, 2000) . The AcMNPV CHIA has an N-terminal signal peptide and, partly due to its Cterminal KDEL motif, is retained in the endoplasmic reticulum (ER) of infected cells (Thomas et al., 1998; Saville et al., 2002) until released upon cell death (Hom et al., 2002) .
Little is known about the post-translational processing, subcellular trafficking or activation of baculoviral cathepsins. The proV-CATH glycan might be required for the putative proV-CATH-CHIA molecular interaction and/or for proV-CATH folding or trafficking (Hom & Volkman, 2000) . The proV-CATH glycan is required for CHIA-assisted folding, implying that proV-CATH enters the ER/Golgi, even though it lacks canonical targeting signals. In a model for proV-CATH glycosylation and proteolytic processing, Slack et al. (1995) suggested that a 32 kDa proV-CATH polypeptide is non-glycosylated and arose due to co-translational N-terminal signal-peptide cleavage. Presumably, proV-CATH enters the secretory route and becomes glycosylated, but is not secreted from cells, despite the absence of any recognized retention mechanisms. Rather, the proenzyme is retained in infected cells until cell death occurs, concomitant with V-CATH catalytic maturation (Hom et al., 2002) .
A comparison of motifs encoded in the Choristoneura fumiferana multiple NPV (CfMNPV) (de Jong et al., 2005) . Cleavage of a preproV-CATH at this site would generate proV-CATH with an N-terminal glycine that could then be an acceptor for myristyltransferase-mediated addition of myristate to the amino end of glycine (Resh, 1999; Maurer-Stroh & Eisenhaber, 2004) . Fig. 1(a) shows putative overlapping cathepsin chymotrypsin-cleavage and myristoylation motifs for most group I NPVs. Orgyia pseudotsugata multiple NPV (OpMNPV) has the equivalent myristyltransferase motif, but lacks the chymotrypsin site. Bombyx mori NPV (BmNPV) has the chymotrypsin site, but lacks the myristyltransferase motif. For C. fumiferana defective multiple NPV (CfdefMNPV), cleavage is predicted after Tyr 11 , but its myristoylation motif is at Gly 13 . Cleavage is also predicted after Phe 11 for Hyphantria cunea NPV (HycuNPV), but this homologue has Cys 12 instead of Gly
12
. Furthermore, the overlapping chymotrypsin and myristoylation motifs are absent in alphabaculovirus group II NPV and betabaculovirus cathepsin N-termini. The predicted N-terminal protein sequences of group I NPV cathepsins are well-conserved, whereas those of group II NPVs and betabaculoviruses are more divergent and usually several residues (5-15 aa) longer. This sequence divergence typically occurs downstream of the 12 conserved N-terminal residues, resulting in a phylogenetic clustering of group I NPV v-cath N-terminal amino acid sequences that is distinct from those of group II NPVs and betabaculoviruses. This sequence analysis suggested that the N-terminus could be cleaved proteolytically, unmasking an N-terminal glycine capable of myristic acid conjugation.
Haemagglutinin (HA) epitope fusions with the C-or N-terminus (or both) of AcMNPV v-cath were generated to monitor cathepsin processing within virus-infected cells (Fig. 2a) . The native contiguous and divergent orientation of chiA to v-cath and of the chiA/v-cath intergenic promoter locus were preserved to allow expression from the native promoters, but the two open reading frames (ORFs) were cloned into the polh locus of a bacmid lacking the native chiA and v-cath ORFs (Kaba et al., 2004) . Thus, the engineered chiA/v-cath expression constructs were studied in the context of an otherwise normal virus infection. Expression of the CfMNPV cathepsin was followed in both its native and the AcMNPV bacmid systems. CfMNPV Cterminal, or C-and N-terminal, HA-tagged cathepsins were cloned adjacent to the AcMNPV chiA in the bacmid polh locus. To eliminate any potential polh promotermediated interference with, or transcription of, chiA or vcath in the polh locus, we deleted the polh promoter and downstream sequence encoding an N-terminal 66His tag and tobacco etch virus (TEV) protease cleavage site (nt 3925-4132) of the pFastBAC HTA transfer plasmid (Fig. 2b) . The pFastBAC mutagenesis and chiA/v-cath constructs were produced as described in the supplementary material (available in JGV Online). Sf 21 cells were infected with AcMNPV bacmid-derived viruses at high m.o.i. (approx. 20) for protein-processing studies. For the glycosylation studies, virus was added to cells, allowed to adsorb for 1 h and the inoculum was replaced with complete Grace's insect medium supplemented with tunicamycin (5 mg ml
21
). Protein samples from cell lysates, treated with the cysteine protease inhibitor E64, were taken from CfMNPV-infected Cf 203 cells and AcMNPV (or bacmid)-infected Sf 21 cells at 72 and 40 h p.i., respectively. Proteins were analysed by Western blotting using either anti-V-CATH antiserum as described by Hom et al. (2002) or anti-HA antibody (Sigma) as per the manufacturer's instructions. Proteins were detected on an X-ray film using the SuperSignal chemiluminescent system (Pierce), and molecular masses were based on PAGE Ruler standards (Fermentas).
Although the predicted products of the AcMNPV and CfMNPV v-cath ORFs differ in length by only 1 aa (323 and 324 aa), analyses by PAGE indicated that the AcMNPV cathepsin migrated at 35 kDa and that of CfMNPV at 40 kDa when expressed in their homologous cell cultures (Fig. 3a, anti-V-CATH panel, lanes Ac, Cf, respectively). There is a similar 5 kDa difference in size between the two homologues when expressed with C-terminal HA fusions in the AcMNPV bacmid/Sf 21 system (Fig. 3a, anti-HA panel, lanes AcC, CfC). By PAGE migration, the native virus-expressed AcMNPV and CfMNPV cathepsins were each about 1 kDa smaller than their respective C-terminal HA-tagged counterparts (proV-CATH-HA), a difference equivalent to the extra 9 aa (about 1 kDa) of the HA tag. Thus, any post-translational processing of CfMNPV cathepsin, such as glycosylation, must be equivalent in both its native and AcMNPV-based bacmid backgrounds. CfC and AcC from tunicamycin-treated cells migrated about 5 kDa faster than those from untreated cells, suggesting that both native cathepsins were glycosylated. However, by PAGE analysis, the CfC cathepsin was about 5 kDa larger than AcC, whereas in tunicamycin-treated cells, CfC was about 1 kDa larger than AcC. Therefore, differences in glycosylation alone cannot account fully for the approximately 5 kDa difference in size between native AcMNPV and CfMNPV proV-CATH.
To demonstrate N-terminal proteolytic processing of preproV-CATH to proV-CATH, mobilities of cathepsin isoforms derived from native AcMNPV pre-proV-CATH, HA-pre-proV-CATH, pre-proV-CATH-HA and HA-preproV-CATH-HA were compared. When the (Ac) HA-preproV-CATH (N-terminal HA) (AcN, Fig. 2a) was expressed, it was detectable with anti-V-CATH serum, but not with anti-HA antibody (Fig. 3c, lane AcN) , suggesting cleavage at the HA-containing N-terminus. The proteins derived from native and HA-pre-proV-CATH were of similar size, suggesting identical N-terminal cleavage sites (Fig. 3c, lanes Ac, AcN) . The proV-CATH derived from pre-proV-CATH-HA (AcC) and HA-pre-proV-CATH-HA (AcNC) were detectable by both anti-V-CATH and anti-HA antibodies (Fig. 3c , lanes AcC, AcNC). Furthermore, both AcC and AcNC had identical PAGE mobilities, migrating about 1 kDa slower than the proV-CATH derived from their respective native pre-proV-CATH (Ac) and HA-pre-proV-CATH (AcN) proteins, both of which lack a C-terminal HA tag (Fig. 3c) . The approximately 1 kDa difference in migration rates demonstrated that only a small N-terminal portion was removed. CfMNPV proV-CATH derived from pre-proV-CATH-HA (CfC) and HA-pre-proV-CATH-HA (CfNC) were both detectable with anti-HA and were of similar size, but were about 1 kDa larger than native CfMNPV-expressed cathepsin, due to the C-terminal HA tag (Fig. 3c, lanes Cf, CfC and CfNC). From this evidence, we suggest that AcMNPV and CfMNPV v-cath mRNAs are translated as pre-proV-CATH polypeptides. The fact that HA-pre-proV-CATH cannot be detected with an anti-HA antibody supports the suggestion by Slack et al. (1995) that co-translational N-terminal cleavage of a pre-proV-CATH occurs, which in our system also removes the N-terminal HA tag.
As N-linked glycosylation occurs in the ER, proV-CATH must somehow be processed in the ER. Although there is no recognizable secretion signal predicted for the Nterminal portion of AcMNPV or CfMNPV pre-proV-CATH, it is presumed to enter the ER, where folding of proV-CATH might be assisted by the viral CHIA and/or other viral or cellular proteins. Prior evidence of AcMNPV proV-CATH glycosylation (and inhibition thereof) is confirmed herein, as it is for CfMNPV proV-CATH.
To localize the baculoviral cathepsin, a C-terminal red fluorescent protein tag (DsRED) was fused to AcMNPV v-cath (Fig. 2a) and expressed from the native v-cath promoter adjacent to chiA in the AcMNPV bacmid polh locus. Transient expression of an ER-targeted green fluorescent protein (GFP) (mGFP5-ER), modified to have an N-terminal signal peptide and a C-terminal ERretention (HDEL) motif (Siemering et al., 1996; Haseloff et al., 1997) under the control of the ie-1/hr5 element in the pDIE1.TOPO plasmid (Shi et al., 2007) , was used to visualize the ER. The diffuse fluorescence pattern (Fig. 3d,  mGFP5 -ER inset) of unmodified eGFP in cells infected with AcEGFP (Hodgson et al., 2007) is markedly different from the largely perinuclear green fluorescence for mGFP5-ER seen in infected cells. The mGFP5-ER fluorescence pattern in uninfected cells (DAPI/mGFP5-ER uninfected control, Fig. 3d ) also differs from that of the mGFP5-ER pattern in infected cells (mGFP5-ER panel, Fig. 3d ). Detailed methods for the co-localization experiment are (Fig. 3d) . This pattern resembles that of the dual anti-CHIA/anti-HDEL immunostained AcMNPV chitinase/ER in Fig. 1 of Thomas et al. (1998) . The fact that both proV-CATH and CHIA localize to the ER permits a CHIA-proV-CATH molecular interaction, such that CHIA could assist trafficking of proV-CATH in infected cells. CHIA has a C-terminal KDEL peptide motif anchoring it to the ER, which may be sufficient following glycosylation of proV-CATH to enable retention of both proteins in the ER of cells and prevent premature secretion of proV-CATH (Thomas et al., 1998; Saville et al., 2002) .
Myristoylation of proteins also influences their subcellular trafficking, as hydrophobic lipid moieties can enable interactions with membranes (Resh, 1999) . Some viruses encode polyproteins for which a myristoylation site, commonly an N-terminal glycine, is unmasked upon proteolytic cleavage. Subsequent addition of an N-terminal lipid moiety can then allow membrane anchoring (MaurerStroh & Eisenhaber, 2004) . Lanier et al. (1996) showed that AcMNPV budded virus (BV)-associated V-CATH helps to degrade cytoskeletal actin shortly after virus entry into cells. An N-terminal proV-CATH myristate could allow an interaction between the proV-CATH and BV envelope. Such a lipid could also mediate interactions with CHIA or other proteins. Perhaps the putative acyl chain provides both lipid-anchoring and protein-interacting functions, or merely confers proV-CATH stabilization in an inactive conformation.
We here report evidence that both the AcMNPV and CfMNPV v-cath ORFs are expressed as pre-proenzymes (pre-proV-CATH). The data showed that AcMNPV V-CATH-DsRED enters the ER and that similar, small N-terminal portions of AcMNPV and CfMNPV pre-proV-CATH homologues are cleaved proteolytically, generating proV-CATH. Similar cleavage of both homologues occurred in their native virus-cell systems and in the AcMNPV bacmid-based system. Although the N-termini of both homologues were cleaved similarly, data from this study also suggested that they have different posttranslational modifications, such as glycosylation, when expressed in both their native and the AcMNPV bacmid system. Furthermore, glycosylation and cleavage Western profiles of the two homologues were identical upon infection of HiFive cells with the same viral constructs (data not shown). Fig. 1(b) is a predicted model for proteolytic processing of pre-proV-CATH, based on our data, and is consistent with the suggestion by Slack et al. (1995) that AcMNPV pre-proV-CATH is cleaved proteolytically at its N-terminus to proV-CATH. The schematic incorporates data from other reports (Slack et al., 1995; Hom & Volkman, 2000) on the glycosylation status of AcMNPV proV-CATH. Furthermore, it predicts that the proenzyme is cleaved proteolytically at Pro 113 to generate mature V-CATH (Slack et al., 1995) . Further research is required to determine how pre-proV-CATH migrates within cells and to confirm that the N-terminal proteolytic-cleavage site generates an N-terminal glycine that is myristoylated.
